A New Workshop Powered by Cannabis Nurses Network is Coming to Cannabis Science Conference Spring 2024
Cannabis Science Conference Spring will host a full-day preconference workshop, Cannabis Nursing: A Paradigm Shift in Healthcare, sponsored by Cannabis Nurses Network and Medical Marijuana 411.
The full-day preconference workshop is sponsored by Cannabis Nurses Network and Medical Marijuana 411.
Cannabis Science Conference (CSC), the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation, and compliance, is thrilled to announce its new and exciting full-day workshop for CSC Spring 2024. Powered by Cannabis Nurses Network™ (CNN), the Cannabis Nursing: A Paradigm Shift in Healthcare workshop is scheduled for May 7, 2024 in Kansas City, Missouri, at the Kansas City Marriott Downtown. The CSC Spring 2024 conference will be held from May 7–May 9.
Designed with the dedicated nursing community in mind, and in honor of National Nurses Week (May 6–May 12), this comprehensive workshop aims to provide nurses with invaluable insights into the therapeutic potential of cannabis in patient care. As the healthcare landscape evolves, nurses play a pivotal role in embracing innovative approaches to enhance patient well-being. This workshop offers a unique opportunity for nurses to deepen their understanding of the industry and provides a collaborative platform that connects nurses with the top minds shaping the future of health care.
Participants will delve into the latest advancements in cannabis research, gaining invaluable expertise and contributing to the ongoing dialogue surrounding its integration into patient care. The workshop will be presented by the CNN Speakers Bureau and will include the following sessions:
- Introduction to Cannabis Nursing: A Journey Through History, Science and Therapeutics
- Legal Considerations for Nurses in Cannabis Medicine
- Essential Knowledge for Cannabis Patient Care: Exploring the NCSBN Guidelines
- Cannabis Use Across the Lifespan: Case Studies and Patient Narratives
- Cannabis Research and the Nurse’s Role: Understanding Addiction, Use Disorder, and Harm Reduction
- The Future of Cannabis Nursing: Impact and Prospects
Join Cannabis Science Conference Spring 2024 for world-class education, networking opportunities and the chance to connect with thought leaders, leading scientists, pioneers in cutting-edge medical applications and industry suppliers.
In addition to the workshop, there are more exciting announcements for this upcoming conference! Julie Kowalski, a distinguished figure in the cannabis science industry, has been named Director of Technical Programming for this conference! Read more about Julie’s expertise and vision for this event. Join us in Kansas City for expert presentations from our Analytical Track, Medical Track, Cultivation Track, and our brand new Compliance Track, chaired by Kim Stuck, CEO of Allay Consulting and author of our Stuck on Compliance blog! See our press release for the inside story.
Save your spot today! For event details and registration for Cannabis Science Conference Spring 2024 and the Cannabis Nursing: A Paradigm Shift in Healthcare workshop, please visit the event page.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
